Skip to main content

Table 5 Side effects as mentioned after treatment

From: Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]

Adverse effect Gabapentin (N = 54) n (%) Placebo (N = 51) n(%) Significance
Dizziness 20 (37.3) 2 (3.9) P = 0.0000
Somnolence 15 (27.8) 3 (5.9) P = 0.003
Lethargy 11 (20.4) 1 (2.0) P = 0.003
Nausea 10 (18.5) 5 (9.8) n.s.
Headache 8 (14.8) 3 (5.9) n.s.
Stomach problems 4 (7.4) 3 (5.9) n.s.
'drunken' 4 (7.4) 0 (0) n.s.
Disturbed gait 4 (7.4) 0 (0) n.s.
Water retention 1 (1.9) 3 (5.9) n.s.
  1. Data on all patients who started treatment and returned for assessment after 3 weeks, with or without completing 3 weeks of treatment. n.s. is 'not significant'